Cellyan Biotechnology (HKPD) Stock Analysis
NASDAQHealthcareMedical - Distribution
What Cellyan Biotechnology does
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Key metrics
ETFs linked to HKPD
Broad-market and Healthcare sector ETFs an investor holding Cellyan Biotechnology is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how HKPD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HKPD in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Cellyan Biotechnology?
- Cellyan Biotechnology trades under the ticker HKPD on NASDAQ.
- Which exchange is HKPD listed on?
- HKPD is listed on NASDAQ.
- What sector does Cellyan Biotechnology operate in?
- Cellyan Biotechnology is classified in the Healthcare sector (Medical - Distribution industry).
- How can PortView help analyze HKPD in a portfolio?
- PortView shows HKPD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.